| 英文别名 |
GSK547;6-{4-[(5S)-5-(3,5-difluorophenyl)-4,5-dihydropyrazole-1-carbonyl]piperidin-1-yl}pyrimidine-4-carbonitrile;GTPL11274;CHEBI:230494;BS-16014;HY-114492;example 6 [WO2020044206A1];ZB1543;CHEMBL4514271;EN300-26570828;SCHEMBL20166101;s8787;EX-A2983;GSK'547;6-[4-[(3S)-3-(3,5-difluorophenyl)-3,4-dihydropyrazole-2-carbonyl]piperidin-1-yl]pyrimidine-4-carbonitrile;D70094;AC-31592;AKOS037648911;Z4119391466;2226735-55-1;RIP1 inhibitor GSK547;CS-0086373;BDBM50507336;GLXC-20225;BPD73555;GSK-547;(S)-6-(4-(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl)piperidin-1-yl)pyrimidine-4-carbonitrile;6-{4-[(5S)-5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl]piperidin-1-yl}pyrimidine-4-carbonitrile;DA-73923 |